LumaCyte
PrivateLast Round
Series B
Sep 6, 2023
Total Funding Raised
$12.67M
Company Overview
LumaCyte is a bioanalytics instrumentation company that produces label-free, single cell analysis instrumentation for research and biomanufacturing applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Drug Discovery, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Subscription SaaS, Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
LumaCyte Comparables
Compare LumaCyte with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ThinkCyte | 86% | |
| LevitasBio | 83% | |
| NanoCellect Biomedical | 83% | |
LumaCyte Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 6, 2023 | ||||
| Series A | Mar 2, 2022 | ||||
| Grant | Aug 30, 2019 | ||||
| Grant | Jan 9, 2019 | ||||
| Grant | Apr 1, 2018 |
Key People
Founding team and executive leadership
LumaCyte Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Carnegie Mellon University Investment Office | Grant |
| Genentech | Grant |
| Rensselaer Polytechnic Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 20% QoQ, from 20 to 24 employees.
- Nov 27, 2023
Grew 20% QoQ, from 20 to 24 employees.
LumaCyte Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about LumaCyte's valuation, stock price, and market status.